tiprankstipranks
ME Therapeutics Holdings, Inc. (TSE:METX)
:METX
Canadian Market

ME Therapeutics Holdings, Inc. (METX) Income Statement

Compare
9 Followers

ME Therapeutics Holdings, Inc. Income Statement

Last quarter (Q4 2024), ME Therapeutics Holdings, Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q4, ME Therapeutics Holdings, Inc.'s net income was $-312.04K. See ME Therapeutics Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Aug 24Aug 23Sep 22
Total Revenue
$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―
Depreciation and Amortization
$ 39.00$ 49.00$ ―
EBITDA
$ -1.29M$ -6.51M$ -57.46K
Operating Income
$ -1.37M$ -6.54M$ -60.28K
Other Income/Expenses
$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―
Net Income
$ -1.29M$ -6.52M$ -57.46K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

ME Therapeutics Holdings, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis